Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeThe Road to a Vaccine

      The Road to a Vaccine: How healthcare advocates are changing the global conversation about COVID-19

      In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.


      In Episode 4 of The Road to a Vaccine, Lisa Ling talks with scientific journalists, healthcare experts and others about the role of social movements—both in the past and today with the COVID-19 pandemic—in driving access to care, building critical disease awareness and more. Guests include journalist David France, Dr. Sudip Parikh, CEO of the American Association for the Advancement of Science, Mary Woolley, President and CEO of grassroots health organization Research!America and Seema Kumar, Vice President, Innovation, Global Health and Science Policy Communication at Johnson & Johnson.
      RTAV: Season 2, Episode 4
      Lisa Ling (middle) talking with Sudip Parikh, Ph.D. (left) and Mary Woolley (right) over video

      Lisa Ling

      Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News’ Nightline.
      RTAV David France headshot

      David France

      France is an award-winning American investigative reporter, non-fiction author and Oscar-nominated documentary filmmaker. His directorial debut, “How to Survive a Plague,” is hailed as an innovative and influential piece of storytelling that is credited with renewing a conversation about AIDS in the United States. His new critically acclaimed documentary film, “Welcome to Chechnya,” premiered at the 2020 Sundance Film Festival and won awards at festivals around the world.
      Seema Kumar

      Seema Kumar

      Kumar is Vice President, Innovation, Global Health and Science Policy Communication at Johnson & Johnson and a world-renowned champion of the value of science and science journalism. Kumar drives public engagement and trust in science through development of storytelling initiatives and programs that create positive societal impact.

      Sudip Parikh, Ph.D.

      Having spent two decades at the nexus of science, policy and business, in January 2020 Parikh became the 19th Chief Executive Officer of the American Association for the Advancement of Science and Executive Publisher of the Science family of journals. An active member of the scientific advocacy community, Parikh serves as a board member and officer for several impactful organizations, including Research!America, Friends of Cancer Research and ACT for NIH.
      RTAV headshot Mary Woolley

      Mary Woolley

      Woolley is the President and CEO of Research!America, the nation’s largest not-for-profit grassroots public education and advocacy organization committed to making medical and health research a higher national priority. Woolley is a longtime leader of advocacy for science, especially medical and health science. She’s also a high-profile speaker, writer and promoter of public engagement by scientists.

      “I was working on a potential COVID-19 vaccine—then my wife got sick”: Meet a researcher whose personal experience is fueling his fight against the pandemic

      Within a matter of weeks, Ramon Polo’s work and home life were completely changed by the novel coronavirus—and he’s a stronger scientist and husband for it.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.